138 related articles for article (PubMed ID: 11185689)
1. [Relapsing polychondritis developing in a patient with Graves' disease: a possible association with propylthiouracil].
Ohya N; Suzuki Y; Ichikawa Y; Ito K
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):30-6. PubMed ID: 11185689
[TBL] [Abstract][Full Text] [Related]
2. ANCA positive relapsing polychondritis, Graves disease, and suspected moyamoya disease: A case report.
Xuan YY; Li TF; Zhang L; Liu SY
Medicine (Baltimore); 2017 Dec; 96(51):e9378. PubMed ID: 29390537
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
4. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
5. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
7. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
8. [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].
Boulenger-Vazel A; Kupfer-Bessaguet I; Gouedard C; Leberre R; Leroy JP; Sonnet E; Desvignes O; Misery L; Sassolas B
Ann Dermatol Venereol; 2005 Jan; 132(1):27-31. PubMed ID: 15746603
[TBL] [Abstract][Full Text] [Related]
9. Propylthiouracil-induced lupus-like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus.
Yamada A; Sato K; Hara M; Tochimoto A; Takagi S; Hizuka N; Takano K
Intern Med; 2002 Dec; 41(12):1204-8. PubMed ID: 12521217
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease accompanied by anti-myeloperoxidase antibody-related nephropathy and autoimmune hepatitis.
Nagai T; Imamura M; Kamiya Y; Mori M
Intern Med; 2004 Jun; 43(6):516-20. PubMed ID: 15283191
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.
Tanemoto M; Miyakawa H; Hanai J; Yago M; Kitaoka M; Uchida S
Am J Kidney Dis; 1995 Nov; 26(5):774-80. PubMed ID: 7485130
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
Finucane FM; O'Connell J; Kinsley BT
Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
[TBL] [Abstract][Full Text] [Related]
13. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis--a case report.
Wang LH; Tsai MJ; Tsai WY; Lee JS; Chiang BL
J Formos Med Assoc; 2000 Aug; 99(8):642-5. PubMed ID: 10969508
[TBL] [Abstract][Full Text] [Related]
16. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
[TBL] [Abstract][Full Text] [Related]
17. Recurrent episodes of arthritis in a hyperthyroid patient.
Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
[TBL] [Abstract][Full Text] [Related]
18. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody.
Hong SB; Lee MH
Dermatology; 2004; 208(4):339-41. PubMed ID: 15178918
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
20. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
